PFI for Pain-Related Anxiety Among Hazardous Drinkers With Chronic Pain

Completed · Not applicable

Conditions studied: Alcohol Problem, Chronic Pain, Alcohol Abuse

In brief

There is a pressing public health need to develop novel interventions that aim to reduce alcohol consumption and concurrent alcohol among hazardous drinkers with comorbid chronic pain. The proposed study will draw upon NIH treatment development guidelines (Stage 1) to translate and innovate past work to address a major public health priority. Specifically, we propose to develop (Phase IA) and pilot test (Phase IB) a brief, integrated, single-session, computer-based personalized feedback intervention (PFI) designed to 1) enhance knowledge regarding adverse pain-related anxiety-alcohol interrelations; and (2) increase motivation and intention to reduce hazardous drinking.

Key facts

Study ID

NCT05036499

Run by

University of Houston

People needed

117

Starts

2021-09-27

Expected to finish

2023-03-15

Last updated by the study team

2023-12-13

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• ≥ 21 years of age
• Current hazardous drinking pattern (AUDIT scores ≥ 8 for males and ≥ 7 for females)
• Current chronic pain (1) on most days of the week (i.e., 4 or more days per week), (2) at an average weekly severity of 3 or greater on a 0-10 numerical rating scale, and (3) for at least three months in duration
• Fluent in English

You may not qualify if…

• Concurrent alcohol or other substance use treatment
• Not being fluent in English
• Current acute psychiatric distress or thought disorder
• Current imminent risk of suicidality

Where it is running

• University of Houston — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.